International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-4
Original Research Article
Atypical Presentations of lung cancers
Published
Dec. 13, 2024
Abstract

Aim: The aim of this study was to examine the frequency of lung cancers presenting with misleading chest X-rays in primary care. Background: Lung cancer is a common cause of cancer death. Misleading chest x rays are resulting in delay in the diagnosis and thereby increasing the mortality. Early diagnosis can help in curative treatment and thereby decreasing the mortality rate. Design of study and setting: this study is a prospective study. It is carried out in 52 lung cancer patients, who were diagnosed in the department of pulmonary medicine between june2012 to august 2014. Method: All diagnosed cases of lung cancer patients in MIMS medical college were included in the study. Chest X-rays and radiologist reports of the patient’s were analyzed. Chest X-rays were categorized into two groups depending on the primary care physician’s notes and radiologist’s report: abnormal but no malignancy suspected (unsuspected malignancy cases); or abnormal with possible malignancy. Results: Of the 52 patients, in 30 patients chest x ray presentation was atypical, not suggestive of malignancy. 22 cases presented with typical radiological features of malignancy. Pneumonia (n=9, 17.3%) was the most common misdiagnosis of lung cancer followed by Collapse (n=7), Pleural effusion (n=6), Lymphadenopathy (n=3), Lung abscess/Cavitation (n=5). Conclusion: Chest X-rays of more than half of malignancy cases are negative. Further investigation is warranted with continuing or changing symptoms, even if the X-ray is not suggestive of malignancy.

Recommended Articles
Loading Image...
Volume-5, Issue-4
Citations
828 Views
270 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved